Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

CTI Completes FDA Meeting for Pixantrone Resubmission

June 14, 2011 11:17 am | News | Comments

Cell Therapeutics, Inc. (CTI) announced it met with the U.S. Food and Drug Administration's Division of Oncology Drug Products (DODP) for re-submitting a New Drug Application (NDA) for pixantrone, for relapsed aggressive non-Hodgkin's lymphoma (NHL) including the potential for accelerated approval based on the PIX301 study results.


New Substances Added to Carcinogens Report

June 14, 2011 11:11 am | News | Comments

The U.S. Department of Health and Human Services (HHS) added eight substances to its carcinogens report, a science-based document that identifies chemicals and biological agents that may put people at an increased risk for cancer.


FDA Approves Potiga

June 14, 2011 10:52 am | News | Comments

GlaxoSmithKline and Valeant Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Potiga (ezogabine) tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.


Tetragenetics Announces Team, Establishes Headquarters

June 14, 2011 10:44 am | News | Comments

Tetragenetics Inc. announced that Marco Cacciuttolo, MD, has been appointed president and chief executive officer and Ben Machielse and Robert Gailus are new to the board of directors. In addition, its headquarters are established in Cambridge, Mass.


Time Lapse Technique Monitors Ovarian Cancer Growth

June 14, 2011 10:38 am | News | Comments

Scientists at Harvard University have created a laboratory model using time-lapse video microscopic technology that allows observation of early stages of ovarian cancer metastasis.


Merck Completes Enrollment for Centric Phase III Trial

June 14, 2011 10:32 am | News | Comments

Merck reported that patient enrollment in a Phase III clinical study, Centric, has been completed.


Gene May Be Linked to Emphysema and Lung Cancer

June 14, 2011 10:09 am | News | Comments

A gene linked to emphysema can also be a factor for developing lung cancer, University of Texas, Southwestern Medical Center research indicates.


Genome Interpretation Engine

June 14, 2011 7:26 am | Product Releases | Comments

Knome announced the release of kGAP 2.0, a genome interpretation engine. kGAP 2.0 underlies the genome interpretation and comparison services that Knome provides researchers who seek to make genomic discoveries.


HPLC Column

June 14, 2011 7:21 am | Drug Discovery & Development | Product Releases | Comments

Thermo Fisher Scientific Inc. announced the release of the Accucore HPLC column range, utilizing Core Enhanced Technology to enhance laboratory workflow and efficiency.


ChanTest Working with FDA

June 14, 2011 7:13 am | News | Comments

ChanTest Corporation has entered into a research collaboration with the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research to improve the prediction of cardiac safety.


NIH Finds New Clues into Aging Process

June 14, 2011 6:57 am | News | Comments

A new National Institutes of Health study provides insights about the interaction between a toxic protein called progerin and telomeres, which cap the ends of chromosomes.


Resverlogix Moves Forward on Atherosclerosis Drug

June 14, 2011 6:53 am | News | Comments

Resverlogix Corp. announced that chronic repeated-dose toxicology studies on its lead compound, RVX-208, support the initiation of its longer duration, Phase 2b, clinical trial ASSURE.


FDA Releases Nanotech Guidance

June 14, 2011 6:49 am | News | Comments

The U.S. Food and Drug Administration released draft guidance to provide regulated industries with greater certainty about the use of nanotechnology, which generally involves materials made up of particles that are one billionth of a meter in size.


Blocking Enzyme Controls Imflammation, Cancer

June 14, 2011 6:46 am | News | Comments

There is an intimate and complex relationship between inflammation and cancer; and it is well established that tumors secrete many different chemicals that attract host cells which drive inflammation and help to support tumor growth.


Ranibizumab May Help Prevent Blindness

June 14, 2011 6:42 am | News | Comments

A study suggests that administering the drug ranibizumab is associated with reducing the magnitude of legal blindness and visual impairment caused by age-related macular degeneration.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.